Trials / Completed
CompletedNCT04111328
the Effect of Different Drugs and Infusion Ways on Degree of Postoperative Comfort
the Effect of Different Drugs and Infusion Ways on Degree of Comfort for Patients Undergoing Spinal Neoplasm Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 600 (actual)
- Sponsor
- Jun Wang · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
To explore the effect of different drugs and infusion ways on degree of postoperative comfort.Patients undergoing spinal neoplasm surgery receive different patient controlled analgesia(PCA) drugs postoperatively,one group is sufentanil,the other is hydromorphone. Then each drug group will be divided into two subgroups according to the infusion way,intravenously,subcutaneously. During the patient controlled analgesia period, patients' degree of comfort,pain score,sleep quality, the degree of side reaction will be recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | intravenous sufentanil | The PCA pumps contain sufentanil . And the pump is connected to participants intravenously . |
| DRUG | subcutaneous sufentanil | The PCA pumps contain sufentanil. And the pump is connected to participants subcutaneously. |
| DRUG | intravenous hydromorphone | The PCA pumps contain hydromorphone. And the pump is connected to participants intravenously . |
| DRUG | subcutaneous hydromorphone | The PCA pumps contain hydromorphone. And the pump is connected to participants subcutaneously. |
| DRUG | intravenous sufentanil and dexmedetomidine | The PCA pumps contain sufentanil and dexmedetomidine. And the pump is connected to participants intravenously . |
| DRUG | subcutaneous sufentanil and dexmedetomidine | The PCA pumps contain sufentanil and dexmedetomidine. And the pump is connected to participants subcutaneously. |
| DRUG | intravenous hydromorphone and dexmedetomidine | The PCA pumps contain hydromorphone and dexmedetomidine. And the pump is connected to participants intravenously. |
| DRUG | subcutaneous hydromorphone and dexmedetomidine | The PCA pumps contain hydromorphone and dexmedetomidine. And the pump is connected to participants subcutaneously |
Timeline
- Start date
- 2019-10-08
- Primary completion
- 2020-09-30
- Completion
- 2020-10-30
- First posted
- 2019-10-01
- Last updated
- 2021-02-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04111328. Inclusion in this directory is not an endorsement.